Biotech · Private company
Auspex Pharmaceuticals, Inc.
Track this companyFree. Adds Auspex Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- SD-809Phase 3 · Chorea Associated With Huntington DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SD-809Phase 3 · Tardive DyskinesiaClinicalTrials.gov · fetched Nov 12, 2026
- SD-809Phase 1 · TOURETTE SYNDROMEClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Addressing Involuntary Movements in Tardive DyskinesiaPHASE3 · COMPLETED · started Oct 31, 2014ClinicalTrials.gov NCT02291861 · fetched Nov 12, 2026
- Reducing Involuntary Movements in Participants With Tardive DyskinesiaPHASE3 · COMPLETED · started Oct 20, 2014ClinicalTrials.gov NCT02198794 · fetched Nov 12, 2026
- A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)PHASE1 · COMPLETED · started Jul 1, 2014ClinicalTrials.gov NCT02674321 · fetched Nov 12, 2026
- Aim to Reduce Movements in Tardive DyskinesiaPHASE2_PHASE3 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02195700 · fetched Nov 12, 2026
- Alternatives for Reducing Chorea in Huntington DiseasePHASE3 · COMPLETED · started Nov 12, 2013ClinicalTrials.gov NCT01897896 · fetched Nov 12, 2026